NO914567L - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridylderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridylderivater

Info

Publication number
NO914567L
NO914567L NO91914567A NO914567A NO914567L NO 914567 L NO914567 L NO 914567L NO 91914567 A NO91914567 A NO 91914567A NO 914567 A NO914567 A NO 914567A NO 914567 L NO914567 L NO 914567L
Authority
NO
Norway
Prior art keywords
thromboxane
addition
preparation
pyridyl derivatives
therapeutic active
Prior art date
Application number
NO91914567A
Other languages
English (en)
Other versions
NO175634C (no
NO914567D0 (no
NO175634B (no
Inventor
Rainer Soyka
Wolfgang Eisert
Thomas Mueller
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO914567D0 publication Critical patent/NO914567D0/no
Publication of NO914567L publication Critical patent/NO914567L/no
Publication of NO175634B publication Critical patent/NO175634B/no
Publication of NO175634C publication Critical patent/NO175634C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO914567A 1990-11-22 1991-11-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridylderivater NO175634C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037112A DE4037112A1 (de) 1990-11-22 1990-11-22 Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (4)

Publication Number Publication Date
NO914567D0 NO914567D0 (no) 1991-11-21
NO914567L true NO914567L (no) 1992-05-25
NO175634B NO175634B (no) 1994-08-01
NO175634C NO175634C (no) 1994-11-09

Family

ID=6418696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914567A NO175634C (no) 1990-11-22 1991-11-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridylderivater

Country Status (19)

Country Link
EP (1) EP0487095B1 (no)
JP (1) JPH04275273A (no)
KR (1) KR920009799A (no)
AT (1) ATE134619T1 (no)
AU (1) AU640063B2 (no)
CA (1) CA2055950A1 (no)
DE (2) DE4037112A1 (no)
DK (1) DK0487095T3 (no)
ES (1) ES2084756T3 (no)
FI (1) FI915484A7 (no)
GR (1) GR3019783T3 (no)
HU (1) HU213676B (no)
IE (1) IE74248B1 (no)
IL (1) IL100097A (no)
NO (1) NO175634C (no)
NZ (1) NZ240677A (no)
PT (1) PT99571B (no)
RU (1) RU2028292C1 (no)
ZA (1) ZA919205B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4216364A1 (de) * 1991-12-14 1993-11-25 Thomae Gmbh Dr K Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
TWI290549B (en) * 2000-06-02 2007-12-01 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
DE10225635C1 (de) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
FI20055498A0 (fi) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamidijohdannaisia
EP2928860A1 (en) * 2012-12-10 2015-10-14 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE4037112A1 (de) 1992-05-27
ES2084756T3 (es) 1996-05-16
HUT60472A (en) 1992-09-28
JPH04275273A (ja) 1992-09-30
FI915484L (fi) 1992-05-23
FI915484A7 (fi) 1992-05-23
DK0487095T3 (da) 1996-06-24
IE914048A1 (en) 1992-06-03
NO175634C (no) 1994-11-09
PT99571B (pt) 1999-04-30
RU2028292C1 (ru) 1995-02-09
IL100097A (en) 1995-07-31
PT99571A (pt) 1992-10-30
ZA919205B (en) 1993-05-21
IE74248B1 (en) 1997-07-16
DE59107462D1 (de) 1996-04-04
AU640063B2 (en) 1993-08-12
NZ240677A (en) 1994-12-22
GR3019783T3 (en) 1996-07-31
KR920009799A (ko) 1992-06-25
IL100097A0 (en) 1992-08-18
HU913644D0 (en) 1992-02-28
NO914567D0 (no) 1991-11-21
NO175634B (no) 1994-08-01
CA2055950A1 (en) 1992-05-23
EP0487095A1 (de) 1992-05-27
FI915484A0 (fi) 1991-11-21
ATE134619T1 (de) 1996-03-15
AU8796491A (en) 1992-05-28
EP0487095B1 (de) 1996-02-28
HU213676B (en) 1997-09-29

Similar Documents

Publication Publication Date Title
NO902099L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylsulfonamider.
NO20023995D0 (no) 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse
DE59202241D1 (de) Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung.
DE69131359D1 (de) Kondensierte Thiazolverbindungen, ihre Darstellung und ihre Anwendung
EP1329218A4 (en) PREVENTIVE / REMEDY AGENTS FOR PORTAL HYPERTENSION
AU640063B2 (en) Pyridyl derivatives
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
ATE445589T1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
FI891807A0 (fi) Menetelmä terapeuttisesti aktiivisten oktahydropyrrolo-pyratsino/2,1-i/indol-2-oni-johdannaisten valmistamiseksi
EP0759297A4 (en) Remedy for pulmonary heart
NO20020475L (no) 2-aminotetralinderivater for terapi av glaukom
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO169841C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive (arylfenyl- eller thienylmethyl)-2,2'-bi-1h-imidazoler